# Supramarginal Resection in Glioblastoma

> **NCT04243005** · NA · ACTIVE_NOT_RECRUITING · sponsor: **St. Olavs Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Supramarginal resection
- **PROCEDURE:** Conventional surgery

## Key facts

- **NCT ID:** NCT04243005
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243005, "Supramarginal Resection in Glioblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04243005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*